Alliance Wealth Advisors (Utah)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Sell
969
-179
-16% -$100K 0.1% 132
2026
Q1
$645K Sell
1,148
-528
-32% -$339K 0.14% 107
2025
Q4
$1.13M Sell
1,676
-855
-34% -$582K 0.25% 90
2025
Q3
$1.62M Sell
2,531
-584
-19% -$354K 0.38% 74
2025
Q2
$1.67M Buy
+3,115
New +$1.49M 0.4% 73

Other funds holding IDXX

Alliance Wealth Advisors (Utah)'s IDXX Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $100K and leaving 969 shares worth $510K. The position accounts for 0.1% of the portfolio, ranked #132.

Alliance Wealth Advisors (Utah) first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.67M in Q2 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 969 shares of Idexx Laboratories worth $510K as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 179 Idexx Laboratories shares in Q2 2026, an estimated $100K.
  • Idexx Laboratories made up 0.1% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #132 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Alliance Wealth Advisors (Utah)'s Idexx Laboratories position peaked at $1.67M in Q2 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.